Immune Repertoire Sequencing Market Global Trends, Market Share, Industry Size, Growth, Opportunities and Market Forecast – 2021 to 2027

Immune Repertoire Sequencing Market was valued at USD 116.2 million in 2020 and is expected to reach 180 million by 2027 at a CAGR 7% 2021-2027.

Immune repertoire sequencing is used extensively for biomarker discovery to improve the success rate and cost-effectiveness of rational drug development. For example, in November 2017, the Center for Commercialization of Cancer Immunotherapy (C3i) began offering T-cell receptor-beta sequencing services in Canada’s Biomarkers and Diagnostics Department. Growing demand for personalized medicine is expected to help the immune repertoire sequencing market growth as personalized medicine uses an individual’s genetic profile to make decisions related to the diagnosis, prevention and treatment of diseases.

Market Segmentation:

By Product Type

• Assay Kits

• TCR kits
• BCR Kits
• Instrument

• NGS
• PCR

 By Application

• Biomarker Discovery
• Cancer Immunotherapy
• Autoimmune Diseases
• Vaccine Development and Efficacy
• Transplant Rejection &Tolerance
• Infectious Diseases
• Other

Key Players

• Illumina, Inc.
• Pacific Biosciences of California, Inc
• Agilent Technologies, Inc
• Oxford Nanopore Technologies, Ltd
• QIAGEN N.V.
• Thermo Fisher Scientific
• F. Hoffmann-La Roche Ltd

Scope of the Report

The research study analyzes the global Immune Repertoire Sequencing industry from 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions, considering multiple aspects some of which are listed below as:

Recent Developments

o Market Overview and growth analysis
o Import and Export Overview
o Volume Analysis
o Current Market Trends and Future Outlook
o Market Opportunistic and Attractive Investment Segment

Geographic Coverage

o North America Market Size and/or Volume
o Latin America Market Size and/or Volume
o Europe Market Size and/or Volume
o Asia-Pacific Market Size and/or Volume
o Rest of the world Market Size and/or Volume

Key Questions Answered by Immune Repertoire Sequencing Market Report

1. What was the Immune Repertoire Sequencing Market size in 2019 and 2020; what are the estimated growth trends and market forecast (2021-2027).

2. What will be the CAGR of the Immune Repertoire Sequencing Market during the forecast period (2021-2027)?
3. Which segments (product type/applications/end-user) were most attractive for investments in 2021? How these segments are expected to grow during the forecast period (2021-2027).
4. Which manufacturer/vendor/players in the Immune Repertoire Sequencing Market was the market leader in 2020?
5. Overview on the existing product portfolio, products in the pipeline, and strategic initiatives taken by key vendors in the market.